This image is not available for purchase in your country.

TGN1412 drug molecule

TGN1412 drug molecule

A617/0170

Rights Managed

This image is not available for purchase in your country.

Please contact your Account Manager if you have any query.

Credit

DR TIM EVANS / SCIENCE PHOTO LIBRARY DR TIM EVANS / SCIENCE PHOTO LIBRARY

Caption

TGN1412 drug molecule. Computer model showing the secondary structure of the drug TGN1412. This drug was shown to have serious side effects during a clinical trial in the UK in 2006 when it caused systemic failure in 6 volunteers. The drug is a monoclonal antibody that activates T cells by binding to CD28 receptors on the cell's surface. T cells are a type of white blood cell and a component of the body's immune system.

Release details

Model release not required. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Add to board
  • Similar {{ mediaType(i) }}